Financial News Feed

Previous Hold Today AKRX ranks #2093 as HOLD CANDIDATE. Next Hold
Today AKRX ranks #2093 as HOLD CANDIDATE.

AKRX stock Akorn

AKRX stock
Akorn

Jpmorgan Chase Capital Xvi JP Morgan Alerian Mlp E (NYSEARCA:AMJ) had an increase of 0.39% in short interest. AMJ’s SI was 4.13 million shares in March as released by FINRA. Its up 0.39% from 4.11 m...

Read more

Akorn Inc (NASDAQ:AKRX) had a decrease of 0.48% in short interest. AKRX’s SI was 8.71 million shares in March as released by FINRA. Its down 0.48% from 8.76 million shares previously. With 1.71M avg...

Read more

Akorn, Inc. (NASDAQ:AKRX) Ratings Coverage Among 4 analysts covering Akorn (NASDAQ:AKRX), 2 have Buy rating, 0 Sell and 2 Hold. Therefore 50% are positive. Akorn had 7 analyst reports since October 17...

Read more

Trading Watch on Shares of Akorn Inc (AKRX)
10:47am, Sunday, 24'th Mar 2019
Investors may be focusing on technical signals for Akorn Inc (AKRX). Looking at the reading from the 20-day moving average vs price signal, we can see that the signal is showing Sell. This is the sign...

Read more

Akorn, Inc. (NasdaqGS:AKRX) currently has a current ratio of 3.42. The current ratio, which is also known as the working capital ratio, is a liquidity ratio that displays the proportion of current ass...

Read more

Traders will be closely monitoring shares of Akorn Inc (AKRX) as the Twiggs Money Flow indicator has ducked below the zero line, indicating possible downward momentum for the name. When Twiggs Money F...

Read more

Earnings Yield is calculated by taking the operating income or earnings before interest and taxes (EBIT) and dividing it by the Enterprise Value of the company. The Earnings Yield for Akorn, Inc. (Nas...

Read more

The stock of Akorn, Inc. (NASDAQ:AKRX) is a huge mover today! The stock increased 4.17% or $0.14 during the last trading session, reaching $3.5. About 2.38M...

Read more

Fiduciary Trust Company decreased Prudential Finl Inc (PRU) stake by 6.64% reported in 2018Q4 SEC filing. Fiduciary Trust Company sold 3,962 shares as Akorn, Inc. (NASDAQ:AKRX) Ratings CoverageAmong 4...

Read more

Momenta Pharmaceuticals Inc. (NASDAQ:MNTA) and Akorn Inc. (NASDAQ:AKRX), are influenced by contrast since they are both players in the Drugs - Generic. These...

Read more

SunTrust Banks Begins Coverage on Akorn (AKRX)
02:04am, Saturday, 23'rd Mar 2019
SunTrust Banks began coverage on shares of Akorn (NASDAQ:AKRX) in a research report report published on Tuesday, MarketBeat.com reports. The firm issued a hold rating and a $4.00 price target on the s...

Read more

Zoetis Inc. (NYSE:ZTS) and Akorn Inc. (NASDAQ:AKRX) compete with each other in the Drugs - Generic sector. We will analyze and compare their analyst...

Read more

BENSALEM, Pa.--(BUSINESS WIRE)--lt;a href="https://twitter.com/search?q=%24AKRX&src=ctag" target="_blank"gt;$AKRXlt;/agt; lt;a href="https://twitter.com/hashtag/classaction?src=hash" target="_blank"gt...

Read more

Evolus Inc. (NASDAQ:EOLS) and Akorn Inc. (NASDAQ:AKRX) have been rivals in the Drugs – Generic for quite some time. Below is a review of each business including various aspects such as institutional...

Read more

Akorn, Inc. (NasdaqGS:AKRX) has posted year over year net profit growth of 15.37104. The net profit number is the nuts and bolts of a firm’s financial health. Healthy and consistent net profit growt...

Read more

News Feed powered by

Proudly made at

Rise Vilnius
in partnership with
Barclays Bank